We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients (2006/25)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00699868
First Posted: June 18, 2008
Last Update Posted: June 4, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Assistance Publique Hopitaux De Marseille
  Purpose
This prospective study evaluate the immune status of patients admitted in ICU.CMV remains dormant in the body, but in people with immune deficiency, CMV could reactivate and cause life-threatening pneumonia.

Condition Intervention
Cytomegalovirus Infection Other: Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings

Study Type: Interventional
Study Design: Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: Cellular Immunity, Cytomegalovirus Infection and Septic Shock in ICU Patients

Resource links provided by NLM:


Further study details as provided by Assistance Publique Hopitaux De Marseille:

Primary Outcome Measures:
  • Bring to light the quantitative and qualitative immunological modifications of the present cells NK before the arisen of an infection to CMV [ Time Frame: 24 months ]

Secondary Outcome Measures:
  • Bring to light the quantitative and qualitative immunological modifications of cells NK in the consequences of an infectious shock [ Time Frame: 24 months ]

Enrollment: 29
Study Start Date: March 2008
Study Completion Date: August 2011
Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Infection to CMV
Other: Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings
Sampling of blood
2
Group "control CMV"
Other: Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings
Sampling of blood

Detailed Description:
Candidates will be screened with medical history and blood tests.Then, 2 groups of 20 patients (with or without CMV reactivation) matched for CMV status will be compared for their immune system against CMV.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age more than 18-year-old
  • Informed consent

Exclusion Criteria:

  • minors,
  • pregnant or lactating women,
  • adults under guardianship,
  • immunosuppression at the entrance to resuscitation,
  • AIDS
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00699868


Locations
France
Hôpital de Sainte Marguerite- Service de Réanimation Médicale
Marseille, France, 13009
Sponsors and Collaborators
Assistance Publique Hopitaux De Marseille
Investigators
Principal Investigator: Jean-Marie FOREL, MD Assistance Publique des Hôpitaux de Marseille
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier: NCT00699868     History of Changes
Other Study ID Numbers: 2007-A01197-46
First Submitted: June 13, 2008
First Posted: June 18, 2008
Last Update Posted: June 4, 2012
Last Verified: June 2012

Additional relevant MeSH terms:
Infection
Cytomegalovirus Infections
Herpesviridae Infections
DNA Virus Infections
Virus Diseases